Alefacept in the Treatment of Psoriasis in Patients for Whom Conventional Therapies Are Inadequate

Publisher： Karger

E-ISSN： 1421-9832|211|3|256-263

ISSN： 1018-8665

Source： Dermatology, Vol.211, Iss.3, 2005-11, pp. : 256-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intramuscular Alefacept Improves Health-Related Quality of Life in Patients with Chronic Plaque Psoriasis

By  

Dermatology, Vol. 206, Iss. 4, 2003-06 ,pp. : 307-315

Karger

Access to resources Recommend Favorite

Dermatologists’ Views and Opinions about Photo(chemo)therapy and Conventional Systemic Psoriasis Therapies: Results from a Belgian Survey

By  

Dermatology, Vol. 213, Iss. 2, 2006-08 ,pp. : 123-133

Karger

Access to resources Recommend Favorite

Topical Treatment Habits in Psoriasis Patients Receiving Adalimumab

By  

Dermatology, Vol. 224, Iss. 3, 2012-03 ,pp. : 228-230

Karger

Access to resources Recommend Favorite

Conversion of Psoriasis Patients from the Conventional Formulation of Cyclosporin A to a New Microemulsion Formulation: A Randomized, Open, Multicentre Assessment of Safety and Tolerability

By  

Dermatology, Vol. 196, Iss. 2, 1998-03 ,pp. : 231-236

Karger

Access to resources Recommend Favorite

Systemic Treatment with Fumaric Acid Esters in Six Paediatric Patients with Psoriasis in a Psoriasis Centre

By  

Dermatology, Vol. 229, Iss. 3, 2014-09 ,pp. : 199-204

Karger

Access to resources Recommend Favorite